Health Canada accepts for review Bavarian Nordic’s application for licensure of single-dose, VLP chikungunya vaccine ...
Bavarian Nordic A/S, a global vaccine company, announced that Health Canada has accepted for review the company’s application for licensure of the single-dose, virus-like particle (VLP) chikungunya vaccine candidate, CHIKV VLP, for immunization to …